EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluating a Polygenic Risk Score for Hepatocellular Carcinoma in Multiethnic Cirrhosis Patients in Texas

Priya B Shetty iD, Nia Choi, Hao T Duong iD, Fasiha Kanwal iD, Saira Khaderi, Amit G Singal iD, Sumeet K Asrani, Michelle Luster, Abeer Al-Sarraj, Ashwin Rao iD, Jinyoung Byun iD, Christopher I Amos iD und 2 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.72375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Priya B Shetty und 13 weiteren Autor:innen. Beteiligte Einrichtung: Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms, Ethnicity. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Cancer Prevention and Research Institute of Texas, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Genome‐wide association studies (GWAS) that were previously conducted in European and Asian cohorts have identified numerous genetic risk factors for hepatocellular carcinoma (HCC) and its precursors and risk factors. A polygenic risk score (PRS) composed of these key SNPs for HCC may be useful for risk stratification in clinical settings for U.S. patients with cirrhosis.

Methods

Using genetic and clinical data from the Texas HCC Consortium cohort, we evaluated a weighted PRS constructed from 11 independent SNPs previously shown to be associated with advanced liver disease ( PNPLA3 – TM6SF2 – GCKR – HSD17B13 – GATAD2A – TRIB2 – PPP1R3B – CPN1 – ERLIN1 – APOE – MBOAT7 ). We used Fine‐Gray competing risk models to estimate hazard ratios (HR) and 95% confidence intervals (CI) to test the association between the PRS and HCC.

Results

The 1888 patient cohort included non‐Hispanic White (NHW; 50.4%), non‐Hispanic Black (NHB; 18.5%), and Hispanic (28.6%) patients, and 116 developed incident HCC. Each unit increase in the PRS was associated with increasing risk of HCC (HR = 2.20; 95% CI (1.53, 3.18)). The 11‐SNP PRS was strongly associated with risk of HCC in NHW patients (HR = 2.53, 95% CI (1.65, 3.89)) but not among NHB and Hispanic patients. Similarly, the magnitude of the PRS effect on HCC risk differed by cirrhosis etiology with the strongest association for cirrhosis due to Hepatitis C (HR = 3.81, 95% CI (1.64, 8.82)).

Conclusions

Our study shows that PRS is generally promising for HCC risk prediction; however, the current PRS that was derived from previous GWAS of primarily NHW and Asian patients is not robust over different groups, limiting their use for risk stratification in diverse populations with different etiologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver CirrhosisLiver NeoplasmsEthnicityAgedFemaleHumansMaleMiddle AgedGenetic Predisposition to DiseaseGenetic Risk ScoreGenome-Wide Association StudyPolymorphism, Single NucleotideRisk AssessmentRisk FactorsTexas

Stichwörter der Autor:innen

ancestry‐specific variantsgenetic epidemiologyliver cancerrisk stratification

Autor:innen und Institutionen

  • Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • School of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
  • Division of Digestive and Liver Diseases, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Priya B Shetty, Hao T Duong, Fasiha Kanwal, Amit G Singal, Ashwin Rao, Jinyoung Byun, Christopher I Amos, Hashem B El-Serag, Aaron P Thrift

Förderung

  • NCI NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • NIEHS NIH HHS
  • NIDDK NIH HHS
  • Center for Innovations in Quality, Effectiveness and Safety
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Environmental Health Sciences

Zitieren

APA

Shetty, P. B., Choi, N., Duong, H. T., Kanwal, F., Khaderi, S., Singal, A. G., Asrani, S. K., Luster, M., Al-Sarraj, A., Rao, A., Byun, J., Amos, C. I., El-Serag, H. B., & Thrift, A. P. (2026). Evaluating a Polygenic Risk Score for Hepatocellular Carcinoma in Multiethnic Cirrhosis Patients in Texas. Cancer Medicine. https://doi.org/10.1002/cam4.72375

Vancouver

Shetty PB, Choi N, Duong HT, Kanwal F, Khaderi S, Singal AG, et al. Evaluating a Polygenic Risk Score for Hepatocellular Carcinoma in Multiethnic Cirrhosis Patients in Texas. Cancer Medicine. 2026. doi:10.1002/cam4.72375

BibTeX
@article{Shetty2026,
  author = {Shetty, Priya B and Choi, Nia and Duong, Hao T and Kanwal, Fasiha and Khaderi, Saira and Singal, Amit G and Asrani, Sumeet K and Luster, Michelle and Al-Sarraj, Abeer and Rao, Ashwin and Byun, Jinyoung and Amos, Christopher I and El-Serag, Hashem B and Thrift, Aaron P},
  title = {Evaluating a Polygenic Risk Score for Hepatocellular Carcinoma in Multiethnic Cirrhosis Patients in Texas},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72375}
}
Kostenlos starten →